Notably, cytotoxic and TH1 effector functions, as well as activating NKRs, have consistently been linked to patient-beneficial cancer immunosurveillance57–59; Vδ1+ cells generally expressed higher amounts of these genes compared to CD8+ T cells (Fig. 4b). Here, CD8A is linked to cancer.